Jesus E. Juarez - Concepedia

Author

Jesus E. Juarez

University of California, Los Angeles ORCID

Also Known As

Arun U. Kishan, J JUAREZ, J. Juarez, J.E. Juarez, Jesus E. Juarez, Jesus Eduardo Juarez, Jesus Juarez, Juan H Moreno Juárez

Publications

526

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles VA Greater Los Angeles Healthcare System Johns Hopkins University Oslo University Hospital Johns Hopkins Medicine

About

Jesus E. Juarez is an author at University of California, Los Angeles specializing in medicine, urology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	100
2	Health Sciences	2	2	46
3	Engineering	1	1	23
4	Geriatrics	1	1	33
5	Head And Neck Surgery	1	1	33

Jesus E. Juarez

Publications

452

Citations

H-Index

Page 1

	Year	Citations
ERK reinforces actin polymerization to power persistent edge protrusion during motility Michelle C. Mendoza, Marco Vilela, Jesus E. Juarez, Science Signaling	2015	99
aPROMISE: A Novel Automated PROMISE Platform to Standardize Evaluation of Tumor Burden in <sup>18</sup>F-DCFPyL Images of Veterans with Prostate Cancer Nicholas G. Nickols, Aseem Anand, Kerstin Johnsson, Journal of Nuclear Medicine	2021	60
Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer Rebecca Levin-Epstein, G. Qiao-Guan, Jesus E. Juarez, Frontiers in Oncology	2020	43
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer Amar U. Kishan, Alison Steigler, James W. Denham, JAMA Oncology	2022	40
Patterns of Care for Elderly Patients With Locally Advanced Head and Neck Cancer Jesus E. Juarez, Jehee Isabelle Choi, Maie A. St. John, International Journal of Radiation OncologyBiologyPhysics Palliative CareGeriatric OncologyNeck CancerElderly PatientsGeriatrics	2017	33
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer Michael Xiang, Ting Martin, Ricky R. Savjani, JAMA Network Open	2021	32
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features Amar U. Kishan, R. Jeffrey Karnes, Tahmineh Romero, JAMA Network Open	2021	28
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate Soumyajit Roy, Tahmineh Romero, Jeff M. Michalski, Journal of Clinical Oncology	2023	27
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging Ting Martin, Andrei Gafita, David Shabsovich, European Urology Oncology UrologyEngineeringHigh-risk Prostate CancerMedical ImagingGenitourinary Cancer	2021	23
Magnetic Resonance Imaging Versus Computed Tomography Guidance for Stereotactic Body Radiotherapy in Prostate Cancer: 2-year Outcomes from the MIRAGE Randomized Clinical Trial Amar U. Kishan, James Lamb, Holly Wilhalme, European Urology Surgical OncologyToxic EffectsMultimodalityTreatment VerificationMagnetic Resonance Imaging	2024	23

Page 1